Heterozygote screening for Tay-Sachs disease: Past successes and future challenges

Current Opinion in Pediatrics

Volumn 8, Issue 6, 1996, Pages 625-629

  Natowicz, Marvin R ^a   Prence, Elizabeth M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE;

DNA DETERMINATION; ETHNIC DIFFERENCE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; MEDICAL RESEARCH; MOLECULAR GENETICS; NERVE DEGENERATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TAY SACHS DISEASE;

EID: 0030471099     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199612000-00014     Document Type: Review

References (30)

1. M2 gangliosidoses. In The Metabolic and Molecular Bases of Inherited Disease, edition 7. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 1995:2839-2879. This is the most comprehensive review of all aspects of the Hex A deficiency disorders.
2. M2 ganglioside immunoreactivity. Neuroscience 1995, 68:1027-1035.
3. Isaksson A, Hultberg B: Serum β-hexosaminidase isoenzymes are precursor forms. Scand J Clin Lab Invest 1995, 55:433-440.
4. Peleg L, Meltzer F, Karpati M, Goldman B: GM2 gangliosidosis B1 variant: biochemical and molecular characterization of hexosaminidase A. Biochem Mol Med 1995, 54:126-132.
5. 192Leu mutation in the alpha-subunit of β-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease. Am J Hum Genet 1996, 59:52-58.
6. Pennybacker M, Liessem B, Moczall H, Tifft CJ, Sandhoff K, Proia RL: Identification of domains in human β-hexosaminidase that determine substrate specificity. J Biol Chem 1996, 271:17377-17382.
7. M2 activator protein. J Biol Chem 1995, 270:24246-24251.
8. Tews I, Perrakis A, Oppenheim A, Dauter Z, Wilson KS, Vorgias CE: Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease. Nat Struct Biol 1996, 3:638-648. This excellent study of the structure of chitobiase has important implications for the structure and function of normal and mutant Hex A.
9. Duquette D, Charrow J: Heterozygote screening for Tay-Sachs disease (TSD) in Chicago: carrier frequency among Irish-Catholic spouses of Jews is higher than in Jews [abstract]. Am J Hum Genet 1992, 51:149.
10. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K: Tay-Sachs disease-carrier screening, prenatal diagnosis, and the molecular era. JAMA 1993, 270:2307-2315.
11. Andermann E, Scriver CR, Wolfe LS, Dansky L, Andermann F: Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French-Canadians, juvenile Tay-Sachs disease in Lebanese Canadians and a Tay-Sachs screening program in the French-Canadian population. In Tay-Sachs Disease: Screening and Prevention. Edited by Kaback MM. New York: Alan R. Liss; 1977:161-188.
12. Triggs-Raine B, Richard M, Wasel N, Prence EM, Natowicz MR: Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England. Am J Hum Genet 1995, 56:870-879.
13. Palomaki GE, Williams J, Haddow JE, Natowicz MR: Tay-Sachs disease in persons of French-Canadian heritage in northern New England. Am J Med Genet 1995, 56:409-412.
14. van Bael M, Natowicz MR, Tomczak J, Grebner EE, Prence EM: Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain. J Med Genet 1996, 33:829-832.
15. Hechtman P, Kaplan F: Tay-Sachs disease screening and diagnosis: evolving technologies. DNA Cell Biol 1993, 12:651-665.
16. Gold RJM, Maag UR, Neal JL, Scriver CR: The use of biochemical data in screening for mutant alleles and in genetic counselling. Ann Hum Genet 974, 37:315-326.
17. Prence EM, Natowicz MR, Zalewski I: Unusual thermolability properties of leukocyte β-hexosaminidase: implications in screening for carriers of Tay-Sachs disease. Clin Chem 1993, 39:1811-1814.
18. Prence EM Zalewski I, Natowicz MR: Unusual thermolability properties of beta-hexosaminidase: studies of enzyme from cultured cells and clinical implications. Am J Med Genet 1996, 65:320-324. This study describes an interesting and unusual biochemical property of β-hexosaminidase.
19. Brown DH, Triggs-Raine BL, McGinniss MJ, Kaback MM: A novel mutation at the invariant acceptor splice site of intron 9 in the HEXA gene [IVS9-1 G->T] detected by a PCR-based diagnostic test Hum Mutat 1995, 5:173-174.
20. Navon R, Khosravi R, Korczyn T, Masson M, Sonnino S, Fardeau M, Eymard B, Lefevre M, Turpin JC, Rondot P, et al.: A new mutation in the HEXA gene associated with a spinal muscle atrophy phenotype. Neurology 1995, 45:539-543.
21. Ozkara HA, Akerman BR, Ciliv G, Topcu M, Renda Y, Gravel RA: Donor splice site mutation in intron 5 of the HEXA gene in a Turkish infant with Tay-Sachs disease. Hum Mutat 995, 5:186-187.
22. Ribeiro MG, Pinto R, Sa Miranda MC, Suzuki K: Tay-Sachs disease: intron 7 splice junction mutation in two Portuguese patients. Biochim Biophys Acta 1995, 1270:44-51.
23. Richard MM, Erenberg G, Triggs-Raine BL: An A-to-G mutation at the +3 position of intron 8 of the HEXA gene is associated with exon 8 skip-ping and Tay-Sachs disease. Biochem Mol Med 1995, 55:74-76.
24. 180->His) in the Hex A alpha-chain gene. Neurology 1996, 47:547-552.
25. M2-gangliosidosis B1 variant. J Med Genet 1966, 33:341-343.
26. Triggs-Raine BL, Feigenbaum ASJ, Natowicz M, Skomorowski M-A, Schuster SM, Clarke JTR, Mahuran DJ, Kolodny EH, Gravel RA: Screening for carriers of Tay-Sachs disease: a comparison of DNA-based and enzyme-based tests. N Engl J Med 1990, 323:6-12.
27. Fernandes MJG, Kaplan F, Clow CL, Hechtman P, Scriver CR: Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazi Jews. Genet Epidemiol 1992, 9:169-175.
28. Committee on Obstetrics: Screening for Tay-Sachs disease. Chicago: American College of Obstetricians and Gynecologists; 1991. American College of Obstetrics and Gynecologists Committee Opinion No. 93.
29. Committee on Genetics: Screening for Tay-Sachs disease. Washington, D.C.: American College of Obstetricians and Gynecologists; 1995. American College of Obstetricians and Gynecologists Committee Opinion No. 162.
30. Broida E, Zeigler M, Eckstein J, Bach G: Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel. Am J Med Genet 1993, 47:213-215.